ESR1 and breast carcinoma: Drawing on the specific imaging capability of p(ERE)2-(PRE)2iRFP713 against the intracellular ER/PR of breast cancer cells in vitro, we proceeded to assess the potential of this plasmid DNA to enable molecular imaging in vivo using human xenograft cancer models.